Expertise
Curta’s leadership has 3 decades of experience and 1,500+ peer-reviewed papers and reports. A senior partner personally oversees the success of every project alongside a multidisciplinary team of experts including health economists, clinicians, and data scientists.
Collaboration
We support small biotech up through top 10 biopharma, and throughout the product lifecycle. Collaboration of Curta’s partners with the communities that create HTA and evidence-based guidelines brings real-world perspective on how to turn HEOR research into meaningful policy-changing evidence.
Innovation
Curta’s partners have been at the forefront of methods to measure and communicate value. As a fully partner-owned company, we prioritize innovative research and nimble problem solving to provide the right evidence at the right time.
Meet Curta
Curta's leadership has more than 30 years in the industry and have been pioneers in establishing and advancing the field. Curta boasts two former ISPOR presidents, innovative thinkers bringing new methods of measuring value, and a top-tier team of scientists to bring the highest level of quality and integrity to all of our client engagements.
I am a heading
Here goes your text … Select any part of your text to access the formatting toolbar.
Our Expertise
Curta presently has an emphasis on early and HTA-compliant modeling, real-world evidence, evidence synthesis (SLR, ITC), and evidence generation to meet global reimbursement requirements, including evidentiary needs to support Medicare price negotiation.
I am a heading
Here goes your text … Select any part of your text to access the formatting toolbar.
I am a heading
Here goes your text … Select any part of your text to access the formatting toolbar.
Recent News
New Research Highlights Gaps in Access to Biomarker Testing for Advanced Endometrial Cancer
Learn More
